Skip to main content
Clinical Trials/JPRN-UMIN000005957
JPRN-UMIN000005957
Recruiting
未知

Evaluation of safety of percutaneous radiofrequency ablation therapy for metastatic or primary lung cancer - Evaluation of safety of percutaneous radiofrequency ablation therapy for metastatic or primary lung cancer

Oita University Faculty of Medicine, Department of Radiology0 sites20 target enrollmentJuly 15, 2011

Overview

Phase
未知
Intervention
Not specified
Conditions
primary or metastatic lung cancer
Sponsor
Oita University Faculty of Medicine, Department of Radiology
Enrollment
20
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 15, 2011
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Oita University Faculty of Medicine, Department of Radiology

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Lesion adjacent to large vessels Cases with active infection Cases with active asthma Cases undergone unilateral pneumonectomy Cases whose performance status is over grade 3 Blood cell count: WBC\<2,000/ul, granulocyte\<1,000/ul Platelet\<5x104/ul or PT\-INR\>1\.5 Forced expiratory volume\<1L Cases deemed to be inadequate for this treatment

Outcomes

Primary Outcomes

Not specified

Similar Trials